

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 9.09204798 |
| 2 | somite rostral/caudal axis specification (GO:0032525) | 6.77772392 |
| 3 | maintenance of protein location in nucleus (GO:0051457) | 6.65107425 |
| 4 | regulation of response to osmotic stress (GO:0047484) | 6.47664433 |
| 5 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 6.47354859 |
| 6 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.40367887 |
| 7 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.99127918 |
| 8 | regulation of cilium movement (GO:0003352) | 5.95222952 |
| 9 | negative regulation of epidermis development (GO:0045683) | 5.80408399 |
| 10 | muscle organ morphogenesis (GO:0048644) | 5.60058074 |
| 11 | rRNA transcription (GO:0009303) | 5.35278205 |
| 12 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.32574227 |
| 13 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.26149083 |
| 14 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.24771885 |
| 15 | protein localization to kinetochore (GO:0034501) | 5.21827448 |
| 16 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 5.19376638 |
| 17 | histone H4-K12 acetylation (GO:0043983) | 5.13651921 |
| 18 | histone H4-K5 acetylation (GO:0043981) | 5.07053304 |
| 19 | histone H4-K8 acetylation (GO:0043982) | 5.07053304 |
| 20 | tachykinin receptor signaling pathway (GO:0007217) | 4.98962986 |
| 21 | primitive streak formation (GO:0090009) | 4.98088354 |
| 22 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.96248689 |
| 23 | negative regulation of telomerase activity (GO:0051974) | 4.92894114 |
| 24 | coenzyme catabolic process (GO:0009109) | 4.85043375 |
| 25 | response to dietary excess (GO:0002021) | 4.82748409 |
| 26 | phenol-containing compound catabolic process (GO:0019336) | 4.71961016 |
| 27 | heterochromatin organization (GO:0070828) | 4.64006062 |
| 28 | mitotic sister chromatid segregation (GO:0000070) | 4.61246956 |
| 29 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.60557194 |
| 30 | cytidine metabolic process (GO:0046087) | 4.49453183 |
| 31 | cytidine catabolic process (GO:0006216) | 4.49453183 |
| 32 | cytidine deamination (GO:0009972) | 4.49453183 |
| 33 | notochord development (GO:0030903) | 4.48231228 |
| 34 | hormone catabolic process (GO:0042447) | 4.44019020 |
| 35 | rRNA methylation (GO:0031167) | 4.32044625 |
| 36 | nucleoside transmembrane transport (GO:1901642) | 4.30497538 |
| 37 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.19770566 |
| 38 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.19255566 |
| 39 | histone H4-K16 acetylation (GO:0043984) | 4.11498259 |
| 40 | protein localization to chromosome, centromeric region (GO:0071459) | 4.07410072 |
| 41 | ventricular system development (GO:0021591) | 3.99371224 |
| 42 | transepithelial transport (GO:0070633) | 3.93263156 |
| 43 | microtubule severing (GO:0051013) | 3.92412886 |
| 44 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.91141571 |
| 45 | positive regulation of digestive system process (GO:0060456) | 3.91003687 |
| 46 | rRNA modification (GO:0000154) | 3.88136100 |
| 47 | chromatin assembly (GO:0031497) | 3.85099875 |
| 48 | protein polyglutamylation (GO:0018095) | 3.81392915 |
| 49 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.77292434 |
| 50 | sister chromatid segregation (GO:0000819) | 3.74091088 |
| 51 | arachidonic acid secretion (GO:0050482) | 3.70474331 |
| 52 | icosanoid secretion (GO:0032309) | 3.70474331 |
| 53 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.70225261 |
| 54 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.70225261 |
| 55 | interferon-gamma production (GO:0032609) | 3.67206146 |
| 56 | regulation of microtubule-based movement (GO:0060632) | 3.65764209 |
| 57 | cellular modified amino acid catabolic process (GO:0042219) | 3.64690537 |
| 58 | DNA replication checkpoint (GO:0000076) | 3.64393383 |
| 59 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.61969661 |
| 60 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.58827375 |
| 61 | quinone metabolic process (GO:1901661) | 3.56232144 |
| 62 | negative regulation of telomere maintenance (GO:0032205) | 3.51324287 |
| 63 | maintenance of protein localization in organelle (GO:0072595) | 3.44789100 |
| 64 | bone trabecula formation (GO:0060346) | 3.37028702 |
| 65 | mitochondrion distribution (GO:0048311) | 3.35224323 |
| 66 | cardiovascular system development (GO:0072358) | 3.32566716 |
| 67 | regulation of translation in response to stress (GO:0043555) | 3.32286979 |
| 68 | pre-miRNA processing (GO:0031054) | 3.31813002 |
| 69 | granulocyte differentiation (GO:0030851) | 3.29145619 |
| 70 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.26568562 |
| 71 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.26086061 |
| 72 | vitamin A metabolic process (GO:0006776) | 3.23167269 |
| 73 | proline transport (GO:0015824) | 3.22963637 |
| 74 | anterior/posterior axis specification (GO:0009948) | 3.21915578 |
| 75 | regulation of telomerase activity (GO:0051972) | 3.19063664 |
| 76 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.15070530 |
| 77 | detection of temperature stimulus (GO:0016048) | 3.12390280 |
| 78 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.10097211 |
| 79 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.09599810 |
| 80 | regulation of gene silencing by miRNA (GO:0060964) | 3.09599810 |
| 81 | regulation of gene silencing by RNA (GO:0060966) | 3.09599810 |
| 82 | trophectodermal cell differentiation (GO:0001829) | 3.09518299 |
| 83 | cell migration involved in gastrulation (GO:0042074) | 3.09396039 |
| 84 | regulation of telomere maintenance (GO:0032204) | 3.08936151 |
| 85 | epoxygenase P450 pathway (GO:0019373) | 3.08869188 |
| 86 | L-ascorbic acid metabolic process (GO:0019852) | 3.08343212 |
| 87 | retinoic acid receptor signaling pathway (GO:0048384) | 3.06930461 |
| 88 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.06552652 |
| 89 | nucleoside transport (GO:0015858) | 3.05574370 |
| 90 | positive regulation of developmental pigmentation (GO:0048087) | 3.01186390 |
| 91 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 3.00586508 |
| 92 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.00023203 |
| 93 | fatty acid derivative transport (GO:1901571) | 2.97853054 |
| 94 | icosanoid transport (GO:0071715) | 2.97853054 |
| 95 | histone arginine methylation (GO:0034969) | 2.97631643 |
| 96 | negative regulation of interleukin-2 production (GO:0032703) | 2.97373964 |
| 97 | intestinal epithelial cell development (GO:0060576) | 2.96560365 |
| 98 | polyketide metabolic process (GO:0030638) | 10.0137592 |
| 99 | doxorubicin metabolic process (GO:0044598) | 10.0137592 |
| 100 | daunorubicin metabolic process (GO:0044597) | 10.0137592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.92898502 |
| 2 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.92898502 |
| 3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.92898502 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.51064006 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.48846904 |
| 6 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.48204828 |
| 7 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 3.41375719 |
| 8 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 3.18312336 |
| 9 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 3.08603284 |
| 10 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.99683904 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.81866094 |
| 12 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.77344631 |
| 13 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.73039712 |
| 14 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.33885070 |
| 15 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.29484873 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.27242435 |
| 17 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 2.17644199 |
| 18 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.13539450 |
| 19 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.04064963 |
| 20 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.96298623 |
| 21 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.91335483 |
| 22 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.90451443 |
| 23 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.87951911 |
| 24 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.80114594 |
| 25 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.79745085 |
| 26 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.74980530 |
| 27 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.69567746 |
| 28 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.64195216 |
| 29 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.61549462 |
| 30 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.57990092 |
| 31 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.57848946 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.54247900 |
| 33 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.54018526 |
| 34 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53694038 |
| 35 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.53688894 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.53396141 |
| 37 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.53365808 |
| 38 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.50539018 |
| 39 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.50373942 |
| 40 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.47529512 |
| 41 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.47094647 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.44783268 |
| 43 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.44497121 |
| 44 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.31426293 |
| 45 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.25019173 |
| 46 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.24290548 |
| 47 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23922291 |
| 48 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.22881211 |
| 49 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.17699649 |
| 50 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.17524685 |
| 51 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.14679264 |
| 52 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.14393827 |
| 53 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.13283378 |
| 54 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11247823 |
| 55 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.05701290 |
| 56 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04889029 |
| 57 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 1.02721433 |
| 58 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.00002177 |
| 59 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.98658215 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98582439 |
| 61 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.98166133 |
| 62 | KDM2B_26808549_Chip-Seq_K562_Human | 0.98016530 |
| 63 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.95389477 |
| 64 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94742195 |
| 65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94203434 |
| 66 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.93954501 |
| 67 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.93754978 |
| 68 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.93323787 |
| 69 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.93302322 |
| 70 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.93065293 |
| 71 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.92506211 |
| 72 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90900657 |
| 73 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.88432483 |
| 74 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.87131929 |
| 75 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.85534727 |
| 76 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82846630 |
| 77 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.81483996 |
| 78 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.81020406 |
| 79 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.79246915 |
| 80 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78197674 |
| 81 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.77640741 |
| 82 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.77059290 |
| 83 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.77042073 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.74939202 |
| 85 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74410896 |
| 86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.73619643 |
| 87 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.71876268 |
| 88 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.71694038 |
| 89 | VDR_22108803_ChIP-Seq_LS180_Human | 0.71119485 |
| 90 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.70343187 |
| 91 | * SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.69738449 |
| 92 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.68700867 |
| 93 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.68401554 |
| 94 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.68065500 |
| 95 | P68_20966046_ChIP-Seq_HELA_Human | 0.67741987 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.67342396 |
| 97 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.67339468 |
| 98 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.67066026 |
| 99 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.67011324 |
| 100 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.65723180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 5.59001358 |
| 2 | MP0006292_abnormal_olfactory_placode | 5.29819613 |
| 3 | MP0005257_abnormal_intraocular_pressure | 4.17833490 |
| 4 | MP0002254_reproductive_system_inflammat | 3.85247707 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 3.76764786 |
| 6 | MP0003890_abnormal_embryonic-extraembry | 3.68014827 |
| 7 | MP0005394_taste/olfaction_phenotype | 3.65503464 |
| 8 | MP0005499_abnormal_olfactory_system | 3.65503464 |
| 9 | MP0004858_abnormal_nervous_system | 2.84931378 |
| 10 | MP0008057_abnormal_DNA_replication | 2.75202298 |
| 11 | MP0002332_abnormal_exercise_endurance | 2.69061382 |
| 12 | MP0005075_abnormal_melanosome_morpholog | 2.67775659 |
| 13 | MP0003122_maternal_imprinting | 2.62230932 |
| 14 | MP0002653_abnormal_ependyma_morphology | 2.37505152 |
| 15 | MP0003121_genomic_imprinting | 2.20219116 |
| 16 | MP0010030_abnormal_orbit_morphology | 2.01520101 |
| 17 | MP0005410_abnormal_fertilization | 1.92132662 |
| 18 | MP0006035_abnormal_mitochondrial_morpho | 1.91956665 |
| 19 | MP0000678_abnormal_parathyroid_gland | 1.90029689 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 1.81080601 |
| 21 | MP0004957_abnormal_blastocyst_morpholog | 1.78291159 |
| 22 | MP0003938_abnormal_ear_development | 1.74969486 |
| 23 | MP0003183_abnormal_peptide_metabolism | 1.74271992 |
| 24 | MP0001293_anophthalmia | 1.66592959 |
| 25 | MP0002277_abnormal_respiratory_mucosa | 1.65530524 |
| 26 | MP0008961_abnormal_basal_metabolism | 1.57168411 |
| 27 | MP0008789_abnormal_olfactory_epithelium | 1.51820370 |
| 28 | MP0010352_gastrointestinal_tract_polyps | 1.49643496 |
| 29 | MP0001672_abnormal_embryogenesis/_devel | 1.45342845 |
| 30 | MP0005380_embryogenesis_phenotype | 1.45342845 |
| 31 | MP0000762_abnormal_tongue_morphology | 1.45217365 |
| 32 | MP0002127_abnormal_cardiovascular_syste | 1.45036706 |
| 33 | MP0000049_abnormal_middle_ear | 1.38829885 |
| 34 | MP0002932_abnormal_joint_morphology | 1.35843467 |
| 35 | MP0003123_paternal_imprinting | 1.34367695 |
| 36 | MP0001348_abnormal_lacrimal_gland | 1.33621011 |
| 37 | MP0002088_abnormal_embryonic_growth/wei | 1.33184783 |
| 38 | MP0003984_embryonic_growth_retardation | 1.31404153 |
| 39 | MP0002233_abnormal_nose_morphology | 1.30782036 |
| 40 | MP0004043_abnormal_pH_regulation | 1.29724526 |
| 41 | MP0004133_heterotaxia | 1.29699930 |
| 42 | MP0003283_abnormal_digestive_organ | 1.28089956 |
| 43 | MP0006082_CNS_inflammation | 1.25754457 |
| 44 | MP0005253_abnormal_eye_physiology | 1.24052006 |
| 45 | MP0002092_abnormal_eye_morphology | 1.23435469 |
| 46 | MP0003787_abnormal_imprinting | 1.23324561 |
| 47 | MP0005391_vision/eye_phenotype | 1.19169818 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.15785041 |
| 49 | MP0002085_abnormal_embryonic_tissue | 1.10754043 |
| 50 | MP0003755_abnormal_palate_morphology | 1.10305850 |
| 51 | MP0002114_abnormal_axial_skeleton | 1.08602200 |
| 52 | MP0003935_abnormal_craniofacial_develop | 1.08325767 |
| 53 | MP0002751_abnormal_autonomic_nervous | 1.07265580 |
| 54 | MP0003119_abnormal_digestive_system | 1.06399962 |
| 55 | MP0000350_abnormal_cell_proliferation | 1.05718447 |
| 56 | MP0006072_abnormal_retinal_apoptosis | 1.05258948 |
| 57 | MP0005248_abnormal_Harderian_gland | 1.04756200 |
| 58 | MP0001849_ear_inflammation | 1.04394465 |
| 59 | MP0000432_abnormal_head_morphology | 1.02843877 |
| 60 | MP0003137_abnormal_impulse_conducting | 1.02004452 |
| 61 | MP0004381_abnormal_hair_follicle | 0.99261014 |
| 62 | MP0005266_abnormal_metabolism | 0.99162129 |
| 63 | MP0000428_abnormal_craniofacial_morphol | 0.97014547 |
| 64 | MP0002084_abnormal_developmental_patter | 0.95228331 |
| 65 | MP0002086_abnormal_extraembryonic_tissu | 0.94694569 |
| 66 | MP0002752_abnormal_somatic_nervous | 0.94001871 |
| 67 | MP0003950_abnormal_plasma_membrane | 0.92334361 |
| 68 | MP0003937_abnormal_limbs/digits/tail_de | 0.91557234 |
| 69 | MP0009046_muscle_twitch | 0.91554664 |
| 70 | MP0008770_decreased_survivor_rate | 0.90891478 |
| 71 | MP0003315_abnormal_perineum_morphology | 0.90789285 |
| 72 | MP0002970_abnormal_white_adipose | 0.88381638 |
| 73 | MP0003077_abnormal_cell_cycle | 0.87650656 |
| 74 | MP0002249_abnormal_larynx_morphology | 0.82959369 |
| 75 | MP0010368_abnormal_lymphatic_system | 0.82556643 |
| 76 | MP0004197_abnormal_fetal_growth/weight/ | 0.81438639 |
| 77 | MP0005195_abnormal_posterior_eye | 0.80983701 |
| 78 | MP0003698_abnormal_male_reproductive | 0.79356170 |
| 79 | MP0002116_abnormal_craniofacial_bone | 0.78294079 |
| 80 | MP0004272_abnormal_basement_membrane | 0.78016673 |
| 81 | MP0001486_abnormal_startle_reflex | 0.75267821 |
| 82 | MP0003861_abnormal_nervous_system | 0.74642858 |
| 83 | MP0005623_abnormal_meninges_morphology | 0.73913610 |
| 84 | MP0000955_abnormal_spinal_cord | 0.72033043 |
| 85 | MP0001286_abnormal_eye_development | 0.71874542 |
| 86 | MP0001984_abnormal_olfaction | 0.68525331 |
| 87 | MP0002132_abnormal_respiratory_system | 0.68058626 |
| 88 | MP0002269_muscular_atrophy | 0.67824273 |
| 89 | MP0004270_analgesia | 0.67731160 |
| 90 | MP0009703_decreased_birth_body | 0.67662062 |
| 91 | MP0002396_abnormal_hematopoietic_system | 0.66954988 |
| 92 | MP0008872_abnormal_physiological_respon | 0.66853646 |
| 93 | MP0005508_abnormal_skeleton_morphology | 0.65342981 |
| 94 | MP0001730_embryonic_growth_arrest | 0.64504196 |
| 95 | MP0002081_perinatal_lethality | 0.64035004 |
| 96 | MP0003136_yellow_coat_color | 0.63829793 |
| 97 | MP0010094_abnormal_chromosome_stability | 0.61716844 |
| 98 | MP0000313_abnormal_cell_death | 0.60544096 |
| 99 | MP0002925_abnormal_cardiovascular_devel | 0.60179580 |
| 100 | MP0001324_abnormal_eye_pigmentation | 0.59694876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 7.03932046 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 5.37736766 |
| 3 | Abnormality of the lower motor neuron (HP:0002366) | 5.14796912 |
| 4 | Rib fusion (HP:0000902) | 5.03127571 |
| 5 | Hepatoblastoma (HP:0002884) | 4.71420771 |
| 6 | Multiple enchondromatosis (HP:0005701) | 4.26294014 |
| 7 | Ependymoma (HP:0002888) | 3.83528662 |
| 8 | Partial duplication of thumb phalanx (HP:0009944) | 3.78854065 |
| 9 | Anomalous pulmonary venous return (HP:0010772) | 3.75998845 |
| 10 | Rectal fistula (HP:0100590) | 3.64786497 |
| 11 | Rectovaginal fistula (HP:0000143) | 3.64786497 |
| 12 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.61289712 |
| 13 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.55432977 |
| 14 | Horizontal nystagmus (HP:0000666) | 3.50710212 |
| 15 | Pendular nystagmus (HP:0012043) | 3.44462873 |
| 16 | Bifid tongue (HP:0010297) | 3.42058276 |
| 17 | Neoplasm of striated muscle (HP:0009728) | 3.38157168 |
| 18 | Hypoplasia of the fovea (HP:0007750) | 3.32575040 |
| 19 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.32575040 |
| 20 | Embryonal renal neoplasm (HP:0011794) | 3.32536920 |
| 21 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.32305720 |
| 22 | Partial duplication of the phalanx of hand (HP:0009999) | 3.28367691 |
| 23 | Intestinal fistula (HP:0100819) | 3.18195335 |
| 24 | Rhabdomyosarcoma (HP:0002859) | 3.17879858 |
| 25 | Abnormality of the pulmonary veins (HP:0011718) | 3.17369436 |
| 26 | Vaginal fistula (HP:0004320) | 3.16347581 |
| 27 | Fused cervical vertebrae (HP:0002949) | 3.08322746 |
| 28 | Sensory axonal neuropathy (HP:0003390) | 3.07384253 |
| 29 | Testicular atrophy (HP:0000029) | 3.06944103 |
| 30 | Hyperventilation (HP:0002883) | 3.05891416 |
| 31 | Astrocytoma (HP:0009592) | 2.83281925 |
| 32 | Abnormality of the astrocytes (HP:0100707) | 2.83281925 |
| 33 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.81957092 |
| 34 | Abnormality of the salivary glands (HP:0010286) | 2.81873474 |
| 35 | Chromsome breakage (HP:0040012) | 2.81310188 |
| 36 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.79097829 |
| 37 | Amyotrophic lateral sclerosis (HP:0007354) | 2.75352999 |
| 38 | Short humerus (HP:0005792) | 2.74706499 |
| 39 | Dyschromatopsia (HP:0007641) | 2.74110489 |
| 40 | Supernumerary spleens (HP:0009799) | 2.73489496 |
| 41 | Periauricular skin pits (HP:0100277) | 2.72165620 |
| 42 | Preauricular pit (HP:0004467) | 2.72165620 |
| 43 | Nasolacrimal duct obstruction (HP:0000579) | 2.67521004 |
| 44 | Abnormal lung lobation (HP:0002101) | 2.65698522 |
| 45 | Upper limb muscle weakness (HP:0003484) | 2.59930845 |
| 46 | Generalized hypotonia (HP:0001290) | 2.59211603 |
| 47 | Concave nail (HP:0001598) | 2.53532467 |
| 48 | Abnormality of the fovea (HP:0000493) | 2.45265934 |
| 49 | Large earlobe (HP:0009748) | 2.42683743 |
| 50 | Preauricular skin tag (HP:0000384) | 2.41973207 |
| 51 | Ragged-red muscle fibers (HP:0003200) | 2.38752069 |
| 52 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.37083984 |
| 53 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.36788428 |
| 54 | Reduced antithrombin III activity (HP:0001976) | 2.35922288 |
| 55 | Trismus (HP:0000211) | 2.30621692 |
| 56 | Villous atrophy (HP:0011473) | 2.27174212 |
| 57 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.27174212 |
| 58 | Nasal polyposis (HP:0100582) | 2.23905213 |
| 59 | Impulsivity (HP:0100710) | 2.22323449 |
| 60 | Congenital stationary night blindness (HP:0007642) | 2.16727926 |
| 61 | Abnormal cartilage morphology (HP:0002763) | 2.15898644 |
| 62 | Abnormality of the pubic bones (HP:0003172) | 2.14028922 |
| 63 | Skin pits (HP:0100276) | 2.13704797 |
| 64 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.12964317 |
| 65 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.12345809 |
| 66 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.12306119 |
| 67 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.11476600 |
| 68 | Hypochromic anemia (HP:0001931) | 2.10780907 |
| 69 | Skin tags (HP:0010609) | 2.10074387 |
| 70 | Duplication of thumb phalanx (HP:0009942) | 2.09494177 |
| 71 | Shawl scrotum (HP:0000049) | 2.08051920 |
| 72 | Prominent occiput (HP:0000269) | 2.07077814 |
| 73 | Meckel diverticulum (HP:0002245) | 2.06947907 |
| 74 | Partial agenesis of the corpus callosum (HP:0001338) | 2.06488940 |
| 75 | Short 5th finger (HP:0009237) | 2.05900153 |
| 76 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.04532252 |
| 77 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.04145063 |
| 78 | Abnormality of the lacrimal duct (HP:0011481) | 2.03919026 |
| 79 | Hypopigmentation of the fundus (HP:0007894) | 2.02141822 |
| 80 | 3-Methylglutaconic aciduria (HP:0003535) | 2.01496066 |
| 81 | Abnormality of the ileum (HP:0001549) | 2.01357829 |
| 82 | Progressive muscle weakness (HP:0003323) | 2.00616549 |
| 83 | Neoplasm of the heart (HP:0100544) | 1.99231262 |
| 84 | Tetraplegia (HP:0002445) | 1.98780548 |
| 85 | Tongue fasciculations (HP:0001308) | 1.97659621 |
| 86 | Abnormality of the musculature of the hand (HP:0001421) | 1.95876857 |
| 87 | Vertebral fusion (HP:0002948) | 1.95193600 |
| 88 | Pseudobulbar signs (HP:0002200) | 1.92819071 |
| 89 | Upper motor neuron abnormality (HP:0002127) | 1.92770254 |
| 90 | Abnormality of the corticospinal tract (HP:0002492) | 1.92451160 |
| 91 | Glioma (HP:0009733) | 1.91539998 |
| 92 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.91471064 |
| 93 | Hand muscle atrophy (HP:0009130) | 1.91314191 |
| 94 | Renal duplication (HP:0000075) | 1.91157990 |
| 95 | Febrile seizures (HP:0002373) | 1.89446091 |
| 96 | Microretrognathia (HP:0000308) | 1.85471505 |
| 97 | Difficulty running (HP:0009046) | 1.82991439 |
| 98 | Abnormality of chromosome segregation (HP:0002916) | 1.81207818 |
| 99 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.80825369 |
| 100 | Combined immunodeficiency (HP:0005387) | 1.79034578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.21613735 |
| 2 | GRK5 | 5.46039833 |
| 3 | GRK6 | 4.53444193 |
| 4 | ERN1 | 3.72816747 |
| 5 | GRK1 | 3.63629810 |
| 6 | ADRBK2 | 3.29843238 |
| 7 | PBK | 3.28221565 |
| 8 | TYRO3 | 2.53441229 |
| 9 | TTK | 2.43858111 |
| 10 | CSF1R | 2.40466472 |
| 11 | MATK | 2.37906409 |
| 12 | STK10 | 2.28348129 |
| 13 | MAPK7 | 2.16903996 |
| 14 | GRK7 | 2.05445990 |
| 15 | TGFBR2 | 2.04816953 |
| 16 | NTRK1 | 1.93640866 |
| 17 | MARK2 | 1.87724359 |
| 18 | BLK | 1.81180233 |
| 19 | MOS | 1.75161549 |
| 20 | WNK1 | 1.67608345 |
| 21 | ICK | 1.62899293 |
| 22 | PRKG2 | 1.39286524 |
| 23 | CDK7 | 1.35165499 |
| 24 | CAMK4 | 1.32260498 |
| 25 | ADRBK1 | 1.17954386 |
| 26 | HIPK2 | 1.15753131 |
| 27 | MAP3K10 | 1.14209920 |
| 28 | CHEK2 | 1.12337346 |
| 29 | EPHA2 | 1.03496760 |
| 30 | MAP2K4 | 1.00548451 |
| 31 | AKT3 | 0.93457154 |
| 32 | ALK | 0.89817137 |
| 33 | CSK | 0.87505874 |
| 34 | PAK4 | 0.84496932 |
| 35 | PLK1 | 0.81334151 |
| 36 | MAP3K7 | 0.75610700 |
| 37 | PAK3 | 0.73707466 |
| 38 | PRKD2 | 0.73280034 |
| 39 | MKNK2 | 0.70463885 |
| 40 | AKT2 | 0.68596026 |
| 41 | PAK6 | 0.66025720 |
| 42 | LATS2 | 0.64788592 |
| 43 | CHEK1 | 0.62027542 |
| 44 | MAP2K6 | 0.61854798 |
| 45 | PRKD3 | 0.60733780 |
| 46 | PDK4 | 0.56739433 |
| 47 | PDK3 | 0.56739433 |
| 48 | EIF2AK2 | 0.55109641 |
| 49 | CDK19 | 0.55000580 |
| 50 | DYRK1B | 0.50100139 |
| 51 | MAP3K9 | 0.46720413 |
| 52 | MAPK12 | 0.46660709 |
| 53 | NTRK2 | 0.45467530 |
| 54 | MTOR | 0.44534355 |
| 55 | STK38 | 0.42950896 |
| 56 | FGFR3 | 0.42051630 |
| 57 | DMPK | 0.41056980 |
| 58 | NEK1 | 0.40555359 |
| 59 | CDK15 | 0.39167908 |
| 60 | DDR2 | 0.38603979 |
| 61 | PAK1 | 0.36467308 |
| 62 | CSNK1E | 0.35720652 |
| 63 | YES1 | 0.35016408 |
| 64 | PDGFRA | 0.33505836 |
| 65 | ERBB2 | 0.33410758 |
| 66 | CDK18 | 0.33325323 |
| 67 | BUB1 | 0.32720334 |
| 68 | TAOK1 | 0.32578926 |
| 69 | CDK14 | 0.32573696 |
| 70 | CDK11A | 0.32514569 |
| 71 | PRKCI | 0.31914728 |
| 72 | CDK8 | 0.31571128 |
| 73 | NEK2 | 0.30412953 |
| 74 | CDK2 | 0.30319052 |
| 75 | TNK2 | 0.30223838 |
| 76 | IGF1R | 0.29325245 |
| 77 | DYRK1A | 0.29324994 |
| 78 | OXSR1 | 0.27474538 |
| 79 | PRPF4B | 0.26902566 |
| 80 | PDK2 | 0.26728789 |
| 81 | PRKCD | 0.26601051 |
| 82 | MAPK10 | 0.26447547 |
| 83 | ATM | 0.25712975 |
| 84 | PTK2 | 0.24612907 |
| 85 | AURKA | 0.24408620 |
| 86 | RIPK1 | 0.24270673 |
| 87 | PRKAA1 | 0.24018140 |
| 88 | SIK2 | 0.21714213 |
| 89 | GSK3A | 0.20830579 |
| 90 | CDC7 | 0.20353018 |
| 91 | RAF1 | 0.20229197 |
| 92 | UHMK1 | 0.19251938 |
| 93 | GSK3B | 0.19212300 |
| 94 | BMX | 0.18365444 |
| 95 | PRKCG | 0.18088975 |
| 96 | INSRR | 0.18036275 |
| 97 | INSR | 0.17787654 |
| 98 | CDK1 | 0.16643652 |
| 99 | TNIK | 0.16635813 |
| 100 | CDC42BPA | 0.16633297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 6.87130380 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 6.46637588 |
| 3 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.63194867 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.03624293 |
| 5 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.77437393 |
| 6 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.66761758 |
| 7 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.62064399 |
| 8 | Galactose metabolism_Homo sapiens_hsa00052 | 2.33854886 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.09401594 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85169103 |
| 11 | Taste transduction_Homo sapiens_hsa04742 | 1.50049896 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 1.47386505 |
| 13 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.45748832 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.33670366 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.33401668 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.31418161 |
| 17 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.20627997 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.17335703 |
| 19 | Thyroid cancer_Homo sapiens_hsa05216 | 1.16162582 |
| 20 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.15283102 |
| 21 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.13260639 |
| 22 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.13067265 |
| 23 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.10746267 |
| 24 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.09438518 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.08988713 |
| 26 | RNA transport_Homo sapiens_hsa03013 | 1.05568028 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00323423 |
| 28 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.99604951 |
| 29 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.97994547 |
| 30 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.97706431 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94287711 |
| 32 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.93126888 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90927461 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85647151 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85121137 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83767618 |
| 37 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82981353 |
| 38 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.82694184 |
| 39 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.79543110 |
| 40 | Pathways in cancer_Homo sapiens_hsa05200 | 0.77822403 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 0.77421985 |
| 42 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77189273 |
| 43 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77165762 |
| 44 | Phototransduction_Homo sapiens_hsa04744 | 0.76131001 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72875061 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70601728 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69889288 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69851858 |
| 49 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69691124 |
| 50 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69462095 |
| 51 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.68677756 |
| 52 | Cell cycle_Homo sapiens_hsa04110 | 0.64314743 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63800131 |
| 54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63578524 |
| 55 | Nicotine addiction_Homo sapiens_hsa05033 | 0.63060549 |
| 56 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.62984443 |
| 57 | Long-term depression_Homo sapiens_hsa04730 | 0.60941819 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60481902 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.58651800 |
| 60 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57717364 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56682693 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55860546 |
| 63 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54364724 |
| 64 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53735140 |
| 65 | Tight junction_Homo sapiens_hsa04530 | 0.53686912 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53398293 |
| 67 | Mismatch repair_Homo sapiens_hsa03430 | 0.51195013 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50863125 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50010483 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49452288 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.49139091 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48029034 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46249347 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45978238 |
| 75 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.43871991 |
| 76 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.43845000 |
| 77 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42939390 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42781144 |
| 79 | Axon guidance_Homo sapiens_hsa04360 | 0.41624746 |
| 80 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.39617750 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39119131 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37851424 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37384909 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.37175703 |
| 85 | Homologous recombination_Homo sapiens_hsa03440 | 0.36508045 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35819688 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.35587087 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34525525 |
| 89 | Morphine addiction_Homo sapiens_hsa05032 | 0.33968336 |
| 90 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.32999977 |
| 91 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.32722565 |
| 92 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30736566 |
| 93 | DNA replication_Homo sapiens_hsa03030 | 0.30332809 |
| 94 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.28626471 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25441715 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24734658 |
| 97 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.24697666 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.24164827 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.23395333 |
| 100 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.23180159 |

